Child and Adolescent Psychopharmacology Made Simple (3rd edition)
Author: John Preston, PsyD, John H. O'Neal, MDl & Mary C. Talaga, RPh, PhD
Course Created: 2015
Practice Level: Intermediate
John Preston, PsyD, John H. O'Neal, MDl & Mary C. Talaga, RPh, PhD
Book Required
Duration:
4
hours
4.7 out of 5.0, Based on: 981 reviews
Course Summary
Child and Adolescent Psychopharmacology Made Simple provides an overview of clinical psychopharmacology for children and adolescents. The course provides information on diagnostics, differential diagnosis, and medication strategies.
Course Format
This course is based on a book and a post test. When you're ready, purchase the test by clicking the "Add To Cart" button. This will let you take the test and receive your certificate for CE credits.
Learning Objectives
- Identify the prevalent rates of depression for teenagers.
- Describe which medication is considered the first line treatment for bipolar disorder.
- Explain how many children with ADHD will experience co-occurring depression.
- Identify the OTC product known for producing significant drug-drug interactions.
Course Syllabus
- Issues in Psychopharmacological Treatment of Children and Adolescents
- Depression
- Bipolar Disorder
- Anxiety Disorders
- Psychotic Disorders
- Attention-Deficit/Hyperactivity Disorder
- Autism Spectrum Disorders
- Miscellaneous Disorders
- Over-the-Counter Medications
s:
This organization, CE4Less, provider #1115, is approved as a provider for social work continuing education by the Association Of Social Work Boards (ASWB) www.aswb.org, through the Approved Continuing Education ACE) program. Ce4Less maintains responsibility for the program. ASWB Approval Period: 8/8/2018-8/8/2021. Social workers should contact their regulatory board To determine course approval. Social workers participating In this course will receive continuing education clock hours.
We are committed to providing our learners with unbiased information. Ce4Less never accepts commercial support and our authors have no significant financial or other conflicts of interest pertaining to the material